127 related articles for article (PubMed ID: 455576)
1. Some effects of chemotherapeutic drugs on bone marrow stem cells. II. Effect on non-Hodgkin lymphoma chemotherapy on various hemopoietic compartments of the mouse.
Duménil D; Sainteny F; Frindel E
Cancer Chemother Pharmacol; 1979; 2(3):203-7. PubMed ID: 455576
[TBL] [Abstract][Full Text] [Related]
2. Some effects of chemotherapeutic drugs on bone marrow stem cells. I. The long-term effects of phase-specific drugs on mouse bone marrow stem cells.
Duménil D; Sainteny F; Frindel E
Cancer Chemother Pharmacol; 1979; 2(3):197-201. PubMed ID: 455575
[TBL] [Abstract][Full Text] [Related]
3. Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
Takano H; Sawada K; Sato N; Natoya A; Tarumi T; Hirayama S; Koizumi K; Takahashi TA; Sekiguchi S; Koike T
Leuk Lymphoma; 1996 May; 21(5-6):473-8. PubMed ID: 9172813
[TBL] [Abstract][Full Text] [Related]
4. Sequential study of the bone marrow granulocytic progenitor cells (CFC *) in children treated by chemotherapy for non-hodgkin malignant lymphomas.
Hartmann O; Parmentier C; Lemerle J; Gout M; Schweisguth O
Nouv Rev Fr Hematol (1978); 1979; 21(3):239-50. PubMed ID: 545314
[TBL] [Abstract][Full Text] [Related]
5. [Effect of hydroxyurea on the number of hematopoietic stem cells, stromal cell precursors and cell precursors of thymus lymphoid tissue in the bone marrow of mice during aging].
Sidorenko AV; Andrianova LF
Tsitologiia; 1984 Jul; 26(7):813-7. PubMed ID: 6485091
[TBL] [Abstract][Full Text] [Related]
6. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
[TBL] [Abstract][Full Text] [Related]
7. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
Miller G; Brashear T; Stone M; Fay J
Int J Cell Cloning; 1991 Sep; 9(5):503-10. PubMed ID: 1955738
[TBL] [Abstract][Full Text] [Related]
8. Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
Hansen PB; Johnsen HE; Ralfkiaer E; Jensen L; Gaarsdal E; Hansen NE
Leuk Lymphoma; 1995 Nov; 19(5-6):453-60. PubMed ID: 8590846
[TBL] [Abstract][Full Text] [Related]
9. [The role of the hemopoiesis-inducing microenvironment in the mechanisms of the regeneration of hemopoiesis after cytostatic exposure].
Dygaĭ AM; Zhadanov VV; Bogdashin IV; Gol'dberg VE
Nauchnye Doki Vyss Shkoly Biol Nauki; 1992; (9):109-16. PubMed ID: 1302526
[TBL] [Abstract][Full Text] [Related]
10. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
11. Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoenia.
Scholz M; Engel C; Loeffler M;
Br J Haematol; 2006 Mar; 132(6):723-35. PubMed ID: 16487172
[TBL] [Abstract][Full Text] [Related]
12. [Role of hematopoietic cells-precursors in the regeneration of hematopoiesis after cytostatic action].
Bogdashin IV; Buznik DV; Dygaĭ AM; Gol'dberg ED
Biull Eksp Biol Med; 1992 Jan; 113(1):50-1. PubMed ID: 1391864
[TBL] [Abstract][Full Text] [Related]
13. Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide.
Fairbairn LJ; Chinnasamy N; Lashford LS; Chinnasamy D; Rafferty JA
Cancer Gene Ther; 2000 Feb; 7(2):233-9. PubMed ID: 10770631
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.
Goldhirsch A; Pirovino M; Sonntag RW; Tschopp L; Ryssel HJ; Brunner KW
Cancer Treat Rep; 1980; 64(2-3):335-7. PubMed ID: 6157468
[TBL] [Abstract][Full Text] [Related]
15. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
OKunewick JP; Buffo MJ; Kociban DL
Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
[TBL] [Abstract][Full Text] [Related]
16. [The 5-fluorouracil sensitivity of the hematopoietic stroma of the bone marrow and spleen].
Starostin VI; Domaratskaia EI; Bueverova EI; Bragina EV
Izv Akad Nauk Ser Biol; 1995; (4):496-500. PubMed ID: 7496318
[TBL] [Abstract][Full Text] [Related]
17. The hematopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene.
Seidel HJ; Barthel E; Zinser D
Exp Hematol; 1989 Mar; 17(3):300-3. PubMed ID: 2917624
[TBL] [Abstract][Full Text] [Related]
18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
19. [Differentiation characteristics of circulating and bone marrow hematopoietic stem cells and the effect of thymus factors].
Popov BV; Ergakova EV
Biull Eksp Biol Med; 1985 May; 99(5):610-3. PubMed ID: 3839146
[TBL] [Abstract][Full Text] [Related]
20. Comparative toxicity of detorubicin and doxorubicin, free and DNA-bound, for hemopoietic stem cells.
Huybrechts M; Trouet A
Cancer Chemother Pharmacol; 1980; 5(2):79-82. PubMed ID: 7471318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
